Skip to content
LAWYER PROFILE

Sidley Austin LLP

Rebecca K. Wood

Washington, DC, USA USA Guide 2021 Ranked in 1 departments
Ranked in : Healthcare: Pharmaceutical/Medical Products Regulatory
chambers review
Lawyer Information
chambers review
Lawyer Information

Lawyer profile for USA 2021

USA

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

USA
Healthcare: Pharmaceutical/Medical Products Regulatory - District of Columbia

Band 3

Rebecca Wood has extensive knowledge of FDA regulations and provides counsel for a range of clients, including pharmaceutical, device and diagnostic manufacturers. Her expertise encompasses fraud and abuse cases and privacy matters.
"She's excellent to work with. She is very knowledgeable, responsive and great at clearly articulating complicated issues." "A seasoned FDA adviser who is really good at sharing her knowledge." "She understands the way the FDA looks at things and how best to approach them."
Learn more about this team View ranking table

Lawyer information

This content is provided by Rebecca K. Wood

Practice Areas

BECKY WOOD serves on Sidley’s Global Life Sciences Leadership Council and leads Sidley’s Washington, D.C. Healthcare and FDA group. She also has served as Global Lead of the Food, Drug and Medical Device Regulatory practice. Becky focuses her practice on counseling clients on FDA regulatory, enforcement, litigation, and transactional matters. Becky was a founding member of the firm’s COVID-19 Task Force, and advises FDA-regulated clients on a range of COVID-19 response efforts, including Emergency Use Authorizations (EUAs) and immunity considerations under the PREP Act. Becky previously served as Chief Counsel to the Food and Drug Administration (FDA) under former Commissioner Scott Gottlieb. At FDA, she worked on virtually every significant initiative addressed by the Commissioner and agency leadership, including efforts to modernize biopharmaceutical, gene therapy and medical device regulation. This role gives her a unique perspective on today’s regulatory environment, as well as insights into the complex issues that our clients face.

USA
Rebecca K. Wood

Sidley Austin LLP

firm
Office

1501 K Street NW

Washington, DC

District of Columbia

USA

20005

guide
Ranked In

USA 2021

View Firm Profile
Share profile:

Discover other lawyers at Sidley Austin LLP

View firm profile
Karen A Popp
Band 4
Karen A PoppSidley Austin LLPLitigation: White-Collar Crime & Government Investigations Washington, DC, USA
Karen A Popp
Band 4
Karen A PoppSidley Austin LLPLitigation: White-Collar Crime & Government Investigations Washington, DC, USA
Mark D Hopson
Band 3
Mark D HopsonSidley Austin LLPLitigation: White-Collar Crime & Government Investigations Washington, DC, USA
Mark D Hopson
Band 3
Mark D HopsonSidley Austin LLPLitigation: White-Collar Crime & Government Investigations Washington, DC, USA
Neal E Sullivan
Band 2
Neal E SullivanSidley Austin LLPSecurities: Regulation: Enforcement Washington, DC, USA
Neal E Sullivan
Band 2
Neal E SullivanSidley Austin LLPSecurities: Regulation: Enforcement Washington, DC, USA
James Mendenhall
Band 4
James MendenhallSidley Austin LLPInternational Trade: CFIUS Experts Washington, DC, USA
James Mendenhall
Band 4
James MendenhallSidley Austin LLPInternational Trade: CFIUS Experts Washington, DC, USA